Tampa, FL, May 8-10, 2008
Note: Unless noted otherwise, physician, nurse, psychologist, and pharmacist credit will be offered.
Saturday, May 10
7:30-9 am
SIG Meeting
(134) Measurement of Pain and Its Impact
This meeting will have two parts: The first will be a formal presentation and discussion about significance of measurement in translational pain research, and the second part will be a discussion about areas of needs for improvement in human clinical and research pain measurement. Speakers include Jianren Mao, MD PhD, and Miroslav Misha Backonja, MD.
9-9:30 am
Frederick W. L. Kerr Basic Science Research Lecture
Stopping Pain in Its Tracts
Karin Westlund High, PhD
.5 CME/CE *
9:30-10 am
Wilbert E. Fordyce Clinical Investigator Lecture
From Poppies to Pill Popping: Is There a Middle Way?
Srinivasa Raja, MD
.5 CME/CE *
10:15-11:45 am
Symposia and Paper Presentations
(318) Clinical Guideline on Chronic Opioid Therapy in
Chronic Noncancer Pain: Process and Progress Report
Perry Fine, MD (Moderator); Christine Miaskowski, PhD RN FAAN;
Roger Chou, MD
1.5 CME/CE
Opioids are indispensable, but potentially problematic, tools in
chronic pain therapy, and their use remains controversial. A
methodologically well-constructed guideline will be an important
step in improving care. APS and the American Academy
of Pain Medicine are collaborating to create an evidence-based
clinical guideline for opioid therapy in the management of
chronic noncancer pain.
(319) How Race and Ethnicity Shape the Experience of Pain Across the Life Span: Findings from Clinical and Experimental Settings
Raymond Tait, PhD (Moderator); Qian Lu, MD PhD; Barbara Hastie,
PhD; Tamara Baker, PhD
1.5 CME/CE
Ethnic differences in pain have been documented, but few
attempts have been made to collectively address the pain
experience across the life span. This symposium will present
empirical data from clinical and experimental settings with
children, young adults, and geriatric populations in multiethnic
samples. Speakers will also examine the influences of race,
ethnicity, culture, psychosocial aspects, and genetics as they
contribute to differences across age, race, and ethnic groups.
(320) Applying Molecular Technologies to Individual Differences in Pain and Analgesia: Merits and Limitations of the Methodologies
William Lariviere, PhD (Moderator); David Clark, MD PhD;
Hyungsuk Kim, DDS PhD
1.5 CME/CE
This symposium will focus on the merits and limitations of
current methods used to study the genetic mechanisms of
individual differences in pain and analgesia; the methods and
data will be discussed in a broad context to better understand
their advantages and disadvantages. The merits of animal
versus human studies will also be highlighted. The overall
goal of the symposium is to educate clinicians and nonmolecular
scientists about the strengths and limitations of current
methodologies.
(321) Cortical Stimulation for Persistent Pain Syndromes: Novel Strategies
Ricardo Cruciani, MD PhD (Moderator); Herta Flor, PhD;
Helena Knotkova, PhD
1.5 CME/CE
This session will focus on transcranial magnetic stimulation
and transcranial direct-current stimulation for pain relief in
patients with neuropathic pain syndromes.
(322) Peripheral Mechanisms Underlying Muscle Pain
Kathleen Sluka, PhD PT (Moderator); Alan Light, PhD;
Ranjini Ambalavanar, PhD; Brian Cairns, PhD ACPR RPh
1.5 CME/CE
Muscle pain is a major problem that costs billions of dollars
in lost wages and health care. The biological mechanisms that
generate and maintain muscle pain are poorly understood, but
likely include peripheral and central mechanisms. Muscle pain
is distinctly different from cutaneous pain because it results
in longer-lasting, more diffuse, and poorly localized pain. This
symposium will highlight recent research on peripheral mechanisms
underlying muscle pain.
(323) Paper Presentations: Human Disease and Models
1.5 CME/CE
1:45-3:15 pm
Symposia and Paper Presentations
(324) Paper Presentations: Treatment Approaches
1.5 CME/CE
(325) Hidden Settings for Health Disparities in Pain: Uncovering the Truth and Policy Implications
Barbara Hastie, PhD (Moderator); April Hazard Vallerand, PhD RN
FAAN; Donna Kalauokalani, MD MPH; Carmen Green, MD
1.5 CME/CE
Disparities in pain have been revealed in settings that seem to
be intuitive venues for unmanaged pain. However, significant
undertreatment of pain occurs in disproportionate numbers in
settings heretofore not considered particularly at risk. Policies
and programs exist that further perpetuate pain disparities,
and patient, provider, and system barriers present challenges
to eradicating these disparities. This symposium will unveil
findings from these settings and address the challenges to
changing practice and research.
(326) Quantitative Sensory Testing for Pain Research and Clinical Practice
Miroslav Misha Backonja, MD (Moderator); David Walk, MD;
Nalini Sehgal, MD; Mark Steven Wallace, MD
1.5 CME/CE
This quantitative sensory testing protocol was developed by the
Neuropathic Pain Research Consortium with the goal of efficiently obtaining quantitative information about the full spectrum
of sensory abnormalities experienced by patients with
pain and painful disorders in clinical and research settings.
(327) Prescribing Opioids: Legal Aspects
Ricardo Cruciani, MD PhD (Moderator); Howard Heit, MD;
Jennifer Bolen, JD; Mark Caverly
1.5 CME/CE
This symposium will address the legal issues that surround
opioid prescribing. Perspectives from a prescribing clinician
and the DEA will be integrated into the discussion. In addition,
practitioners will learn about legal issues and how to
address them.
(328) Incorporating Integrative Medicine in Pain Management
Gary Deng, MD PhD (Moderator); Stephen Sagar, MD; Kathleen Wesa, MD
1.5 CME/CE
Complementary therapies are nonpharmacologic, noninvasive
means of assisting the management of pain and other symptoms.
These therapies are evidence based, helpful, pleasant
and inexpensive, and they may reduce the amount of pain
medication required or serve as viable alternatives to medication
in some situations. These therapies should be considered
as part of pain management programs.
(329) Preclinical Models of Low Back Pain
Laura Stone, PhD (Moderator); Jun-Ming Zhang, MD;
Beth Winkelstein, PhD; Weiyong Gu, PhD
1.5 CME/CE
A lack of appropriate research models has hampered an
improved understanding of the mechanisms underlying
persistent back pain and the development of effective therapies.
This symposium will present current advances on the
development, validation, and use of animal models for low
back pain. Several perspectives will be presented including
inflammatory, neuroimmune, and biomechanical contributors
to low back pain.
* Not eligible for pharmacist credit.
